Synthetic cannabinoid (derivative of tetrahydrocannabinol) used in the USA, Canada and UK as an antiemetic in cancer patients. Currently no approval in Germany.
Please login to access all articles, images, and functions.
Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).
Please complete your registration to access all articles and images.
To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.
Prof. Dr. med. Peter Altmeyer